Therapeutic plasma exchange in critically ill children: experience of the pediatric intensive care unit of two centers in Chile

Files
Therapeutic plasma exchange in critically ill children experience of the pediatric intensive care unit of two centers in Chile (1).pdf (1.83 MB)
Date
2021-06-04
Authors
item.contributor.advisor
item.page.orcidurl
0000-0003-4763-074X
 https://doi.org/10.1016/j.transci.2021.103181
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
item.page.isbn
item.page.issn
1473-0502
item.page.issne
item.page.doiurl
URI
http://hdl.handle.net/20.500.12254/2159
Abstract
Introduction : Therapeutic plasma exchange (TPE) is an extracorporeal blood purification technique used in a wide spectrum of diseases. We aim to review the indications, complications, and outcomes of critically ill children who received TPE and to compare a membrane versus centrifugal method in this cohort. Methods : A retrospective observational study in two pediatric intensive care units in Chile during eight years (2011–2019) Results: A total of 36 patients underwent 167 TPE sessions (20 centrifugation and 16 membrane- based). The more frequent indications for TPE were autoimmune neurological diseases in 14 cases, renal diseases (9), and rheumatological disorders (5). 58% of children received other immunomodulatory therapy. According to ASFA, 45% of cases were I-II category, 50% to III, and 5% not classified. Response to treatment was complete in 64% (23/36) and partial in 33% (12/36). Complications occurred in 17.4% of sessions, and the most frequent was transient hypotension during the procedure. Overall survival at discharge from the PICU was 92%. Patients who received TPE as a single therapy (n = 26) survived 96%. The clinical outcomes between the two apheresis methods were similar. Survivors had a significantly lower PELOD score on admission (14.5 vs. 6.5, p= 0.004). Conclusions: TPE is mainly indicated as a rescue treatment in neurological autoimmune diseases refractory to conventional immunomodulatory treatment. Complications in critically ill children are mild and low. The outcome in children requiring TPE as a single therapy is good, and no differences were observed with centrifugation or membrane method.
Description
El texto quedará disponible en el Repositorio Institucional luego de 12 meses de su publicación debido al embargo definido por la editorial
item.page.coverage.spatial
item.page.sponsorship
Citation
Transfus Apher Sci.2021;60(5):103181. DOI: 10.1016/j.transci.2021.103181
Keywords
item.page.dc.rights
Atribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL)
item.page.dc.rights.url
http://creativecommons.org/licenses/by-nc-sa/3.0/cl/
Collections
Artículos de Revistas